Ideaya Biosciences Inc (IDYA)

Feb 01, 2025

IDYAIDEAYA Biosciences, Inc. Latest Stock News & Market Updates - StockTitan

Feb 01, 2025

Jan 31, 2025

IDEAYA Awards Strategic Stock Options Package: Key Details for New Hires Revealed - StockTitan

Jan 31, 2025

Jan 30, 2025

12 Stocks That Will Double in 2025 - Insider Monkey

Jan 30, 2025

Jan 30, 2025

Uncover the Top 12 Stocks Set to Skyrocket by 2025! - Reporteros del Sur -

Jan 30, 2025

Jan 30, 2025

Here’s Why IDEAYA Biosciences, Inc. (IDYA) Will Double in 2025 - Insider Monkey

Jan 30, 2025

Jan 28, 2025

BTIG reiterates Buy on Ideaya stock, cites significant updates - MSN

Jan 28, 2025

Jan 27, 2025

Mizuho Initiates Coverage of IDEAYA Biosciences (IDYA) with Outperform Recommendation - MSN

Jan 27, 2025

Jan 27, 2025

IDEAYA Biosciences to Participate in Upcoming February 2025 Investor Relations Events - Nasdaq

Jan 27, 2025

Jan 27, 2025

IDEAYA Biosciences to Present at Major Healthcare Investment Conferences - StockTitan

Jan 27, 2025

Jan 26, 2025

(IDYA) Technical Data - Stock Traders Daily

Jan 26, 2025

Jan 26, 2025

Here's Why We're Not Too Worried About IDEAYA Biosciences' (NASDAQ:IDYA) Cash Burn Situation - Yahoo Finance

Jan 26, 2025

Jan 23, 2025

Cantor Fitzgerald Weighs in on IDYA FY2025 Earnings - Defense World

Jan 23, 2025

Jan 22, 2025

Brokers Issue Forecasts for IDYA FY2025 Earnings - MarketBeat

Jan 22, 2025

Jan 21, 2025

BTIG reiterates Buy on Ideaya stock, cites significant updates By Investing.com - Investing.com Canada

Jan 21, 2025

Jan 21, 2025

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Stock Holdings Lifted by JPMorgan Chase & Co. - Defense World

Jan 21, 2025

Jan 21, 2025

JPMorgan Chase & Co. Grows Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - MarketBeat

Jan 21, 2025

Jan 21, 2025

Ideaya stock touches 52-week low at $22.15 amid market challenges - MSN

Jan 21, 2025

Jan 20, 2025

Short Interest in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Expands By 10.1% - MarketBeat

Jan 20, 2025

Jan 19, 2025

IDEAYA Biosciences (IDYA): A Down Year Presents a Window of Opportunity for Investors - MSN

Jan 19, 2025

Jan 18, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Hits New 1-Year LowHere's Why - MarketBeat

Jan 18, 2025

Jan 18, 2025

IDEAYA Biosciences’ (IDYA) “Outperform” Rating Reiterated at Royal Bank of Canada - Defense World

Jan 18, 2025

Jan 17, 2025

Ideaya stock touches 52-week low at $22.15 amid market challenges By Investing.com - Investing.com South Africa

Jan 17, 2025

Jan 17, 2025

Leerink Partners Downgrades IDEAYA Biosciences (IDYA) - MSN

Jan 17, 2025

Jan 15, 2025

Learn to Evaluate (IDYA) using the Charts - Stock Traders Daily

Jan 15, 2025

Jan 15, 2025

Royal Bank of Canada Reaffirms "Outperform" Rating for IDEAYA Biosciences (NASDAQ:IDYA) - MarketBeat

Jan 15, 2025

Jan 14, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Given “Overweight” Rating at Cantor Fitzgerald - Defense World

Jan 14, 2025

Jan 13, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Receives "Overweight" Rating from Cantor Fitzgerald - MarketBeat

Jan 13, 2025

Jan 13, 2025

IDEAYA Biosciences Announces Participation at the 43rd Annual J.P. Morgan Healthcare Conference and 2025 Corporate Guidance - The Malaysian Reserve

Jan 13, 2025

Jan 12, 2025

IDEAYA Biosciences Announces Participation at the 43rd Annual J.P. Morgan Healthcare Conference and 2025 Corporate Guidance – Company Announcement - Financial Times

Jan 12, 2025

Jan 12, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Hits New 12-Month Low – Here’s Why - Defense World

Jan 12, 2025

Jan 10, 2025

Ideaya Biosciences stock hits 52-week low at $24.14 By Investing.com - Investing.com Australia

Jan 10, 2025

Jan 10, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Reaches New 1-Year LowShould You Sell? - MarketBeat

Jan 10, 2025

Jan 10, 2025

Ideaya Biosciences stock hits 52-week low at $24.14 - Investing.com

Jan 10, 2025

Jan 10, 2025

Analysts Set IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Price Target at $53.67 - MarketBeat

Jan 10, 2025

Jan 10, 2025

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Jan 10, 2025

Jan 07, 2025

IDEAYA Biosciences' SWOT analysis: oncology biotech stock's potential and risks - Investing.com Australia

Jan 07, 2025

Jan 07, 2025

IDEAYA Biosciences' SWOT analysis: oncology biotech stock's potential and risks By Investing.com - Investing.com South Africa

Jan 07, 2025

Jan 07, 2025

Principal Financial Group Inc. Sells 4,968 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

Jan 07, 2025

Jan 03, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Sees Strong Trading VolumeWhat's Next? - MarketBeat

Jan 03, 2025

Jan 03, 2025

Another Major DLL3 ADC Alliance As Hengrui Links With IDEAYA - News & Insights

Jan 03, 2025

Jan 02, 2025

Pfizer exits Sangamo pact; Roche, Ideaya strike ADC deals - BioPharma Dive

Jan 02, 2025

Jan 02, 2025

IDEAYA Biosciences in-licenses Hengrui’s SHR-4849 - The Pharma Letter

Jan 02, 2025

Dec 31, 2024

Ideaya, Hengrui join hands in $1B deal for phase I ADC targeting DLL3 - BioWorld Online

Dec 31, 2024

Dec 31, 2024

IDEAYA Biosciences Enters into Exclusive License Agreement with Hengrui Pharma - Defense World

Dec 31, 2024

Dec 30, 2024

IDEAYA Biosciences Enters Exclusive License with Hengrui Pharma for SHR-4849, a Novel Phase 1 DLL3 Topo-I-Payload ADC Targeting SCLC and NET Solid Tumors - Kilgore News Herald

Dec 30, 2024

Dec 30, 2024

Ideaya Biosciences stock hits 52-week low at $24.38 By Investing.com - Investing.com Nigeria

Dec 30, 2024